Cell Cycle Analysis Market Research Report – Forecast to 2027

Cell Cycle Analysis Market: Information by Product (Consumables, Instruments, & Others), Application (Cell Identification and Others), End-User (Academics & Research Institutions, Hospitals & Diagnostic Laboratories, & Others) – Global Forecast Till 2027

ID: MRFR/LS/0202-HCR | October 2022 | Region: Global | 85 Pages         

Cell Cycle Analysis Market Overview


During the forecast year, the cell cycle analysis market is predicted to grow rapidly. Cell cycle analysis tools are employed in a wide range of life science research activities, as well as biomedical and clinical research facilities. Cell cycle analysis is used to examine the impact of numerous internal and external influences on cells. It aids in the differentiation of cells in different stages of the cell cycle and is used to measure the cellular response to biological stimulations and various drugs.


Cell cycle study has historically been performed using sensitive fluorescence detection technologies like flow cytometry and laser scanning cytometry. The rising awareness and use of cell cycle analysis devices among research and academic organizations have fueled the market's expansion. Increased corporate spending on cell level research, government efforts for cell research, growing chronic genetic illnesses, rising prevalence of cell-specific diseases and cancer, and aggressive strategies by market competitors are projected to boost market expansion.


Covid-19 Analysis


With the rise of the Covid-19 impact, many large-scale businesses and industries suffered, except healthcare and life support products. The lockdown and physical distancing protocols have affected millions of small and big business institutions alike. . Pharmaceutical and biotech businesses, along with governments across the globe, are collaborating to handle the Covid-19 epidemic, from vaccine research to planning for pharmaceutical supply chain issues.


However, the effects of the pandemic are anticipated to wear off in a few years. Hence, the cell cycle analysis marketwill revive its market share and industrial expansion. Moreover, the key players of the market are adopting many trends such as product launches and acquisitions to expand their global sales span. So, the cell cycle analysis market will witness substantial growth in the forecast years.


Cell Cycle Analysis Market Dynamics


Drivers


The cell cycle analysis market value is predicted to increase rapidly because of corporate government funding for cell-based research, the rising prevalence of chronic genetic illnesses, the expanding healthcare sector and rising healthcare expenditures, the increasing incidence of cancer, and technical improvements.


Opportunities


Increased corporate spending on cell level research, government efforts for cell research, growing chronic genetic illnesses, rising prevalence of cell-specific diseases and cancer, and aggressive strategies by market competitors are projected to boost the cell cycle analysis market growth. Moreover, the key players of the market are adopting various R&D initiatives and industry trends such as product launches to fuel market expansion.


Restraints


The high cost of automated cell cycle analysis devices, as well as researchers' unwillingness to employ sophisticated cell cycle analysis methodologies, may limit the Cell Cycle Analysis Market growth. Also, cell cycle analysis tools are quite costly and huge. It also needs a significant amount of upkeep, which is unlikely to be practical for small research organizations. As a result, it is hard for the smaller research groups to gain access to such equipment when urgent diagnostic findings are necessary on-site.


Challenges


The high prices of cell analysis devices and costly maintenance may be an issue for small research organizations, limiting the cell cycle analysis market share expansion throughout the assessment phase. Another potential hindrance for the market is the researchers' unwillingness to employ sophisticated cell cycle analysis methodologies.


Cumulative Growth Analysis


During the forecast year, the cell cycle analysis market is predicted to grow rapidly. Cell cycle analysis tools are employed in a wide range of life science research activities, as well as biomedical and clinical research facilities. Cell cycle analysis is used to examine the impact of numerous internal and external influences on cells. It aids in the differentiation of cells in different stages of the cell cycle and is used to measure the cellular response to biological stimulations and various drugs.


Value Chain Analysis


Cell cycle analysis is a technique frequently employed in biological research & clinical diagnostics. It aids in the differentiation of cells in different stages of the cell cycle and is used to measure the cellular response to biological stimulations or various drugs. Cell cycle study has historically been performed using sensitive fluorescence detecting technologies like flow cytometry or laser scanning cytometry. The rising awareness and use of cell cycle analysis devices among research and academic organizations have fueled the market's expansion.


The existence of multiple well-established and small companies defines the market for cell cycle analysis. The global cell cycle analysis market looks to be extremely competitive and fragmented. Global firms are strengthening their foothold in emerging markets, placing pressure on regional businesses, particularly in terms of attributes such as kind, product ranges, and pricing. The market is seeing increased competition, which is likely to increase further throughout the forecast period. These firms have state-of-the-art production facilities as well as a robust sales and distribution network, which has helped them attain market leadership.


Cell Cycle Analysis Market Segment Overview


The globalcell cycle analysis marketis classified into many segments, such as product, application, and end-user. Listed below are the cell cycle examination market segments:


By Product



  • Instruments

  • Microscopes



  • Electron Microscopes

  • Stereomicroscopes

  • Phase Contrast Microscopes

  • Inverted Microscopes

  • Near-Field Scanning Optical Microscopes (NSOM)

  • Fluorescence And Confocal Microscopes




    • Other Microscopes


  • Spectrophotometer





      • Microplate Spectrophotometers

      • Fluorescence Microplate Readers


    • Colorimeters


  • Cell Counter





      • Manual Cell Counters

      • Automated Cell Counters


    • Hemocytometers

    • Cell Microarrays


  • Flow Cytometry





      • Flow Cytometry Software


    • Flow Cytometry Instruments

    • qPCR


  • High Content Screening (HCS) Systems





      • HCS Software


    • Cell Imaging and Analysis HCS Systems


  • Consumables





      • Reagents

      • Microplates



  • Assay Kits






        • Immunoassay


      • Cell-Based Assay


    • Other Consumables



By Application



  • Cell Identification

  • Cell Signaling Pathway/Signal Transduction

  • Target Identification

  • Cell Counting and Quality Control

  • Cell Structure Study

  • Validation and Single-Cell Analysis

  • Cell Viability

  • Cell Proliferation

  • Cell Interaction


By End-User



  • Hospitals And Diagnostic Laboratories

  • Academics And Research Institutions

  • Pharmaceuticals (CROs and Biotechnology Companies)

  • Others


Cell Cycle Analysis Market Regional Analysis


The cell cycle analysis market analysis division comprises North America, Europe, Asia Pacific, and the rest of the world. Because of the availability of great research and development facilities, government funding to stimulate cell-level research and development, and the increased frequency of cancer, the Americas are expected to dominate the cell cycle analysis market. Around15.5 million cancer cases were discovered in the United States in 2016. In 2017, the total cost of cancer care was about USD 147.3 billion.


The European market is predicted to be the second-largest in terms of cell cycle analysis. This region's market growth may be ascribed to the adoption of cutting-edge technologies. Furthermore, a rising number of life sciences and medical research institutes in Europe are adding to the region's market growth.


Due to expanding expenditures on life science and healthcare research, as well as government backing and beneficial regulations for the research industry, Asia-Pacific is predicted to have the fastest-growing share over cell cycle analysis market forecast. Due to the underfunded research industry, a shortage of technical expertise, and inadequate research and development facilities, the Middle East and Africa market is predicted to account for the smallest proportion of the market.


Cell Cycle Analysis Market Competitive Landscape


The cell cycle analysis industry is dominated by a few companies that play a vital role in market growth. These cell examination equipment provider companies are called key companies of the market. They contribute to the largest share of the market profit.


The companies account for the market profits by adopting various cell cycle analysis market trends such as joint ventures, product launches, company expansions, and procurements.


Key Players


Below are the key companies that cell cycle analysis equipment in the global market:



  • Becton, Dickinson, and Company

  • Thermo Fisher Scientific Inc.

  • GE Healthcare

  • Olympus Corporation

  • Promega Corporation

  • Miltenyi Biotech

  • Merck & Co. Inc.

  • Danaher Corporation

  • Agilent Technologies Inc.

  • PerkinElmer Inc.

  • Bio-Rad Laboratories Inc.

  • Nexcelom Bioscience LLC.


Recent developments



  • In March 2018, Agilent Technology, a leading competitor in the cell cycle analysis industry, paid USD 250 million for sophisticated analytical technologies.

  • In April 2016, Genomix Nutrition procured San Antonio Nutrigenomic Laboratory for genetic testing. The merger will enable the firm to provide patients with faster test results. This will also boost operational efficiency, assuring that the company's nutrigenomic tests stay inexpensive and available to providers and patients.

  • In March 2016, Thermo Fisher finalized its long-awaited procurement of Affymetrix. It would provide Thermo Fisher with a broader antibody portfolio, bolstering its position as a health sciences leader, and additional genetic analysis capabilities to better serve clinical and application markets.


Report Overview


This report delivers all the information about the global cell cycle analysis market sizein the forecast period. It also contains different sections of the market analysis to help obtain detailed information such as opportunities, challenges, drivers, Covid-19 analysis, regional analysis, competitive landscape, and others. Moreover, all the information is collected from verified primary and secondary sources to provide the expected cell cycle analysis market outlook by 2027.


Report Details 



  • Historical Period: 2015-2020

  • Base Year: 2021

  • Forecast Period: 2022-2027


Geographically



  • Europe

  • Asia-Pacific

  • North America

  • Middle East & Africa

  • Rest of the world



Report Scope:

Report Attribute/Metric Details
  Market Size   2027: Significant Value
  CAGR   2020-2027: Substantial CAGR
  Base Year   2019
  Forecast Period   2020-2027
  Historical Data   2018
  Forecast Units   Value (USD Million)
  Report Coverage   Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
  Segments Covered   Product, Application and End-User
  Geographies Covered   North America, Europe, Asia-Pacific, and Rest of the World (RoW)
  Key Vendors   Becton, Dickinson and Company, Merck & Co., Inc., Thermo Fisher Scientific, Inc., Danaher Corporation, GE Healthcare, Agilent Technologies, Inc., Olympus Corporation, PerkinElmer, Inc., Promega Corporation, Bio-Rad Laboratories, Inc., Miltenyi Biotech, Nexcelom Bioscience LLC.
  Key Market Opportunities

  • Increasing chronic genetic diseases
  • government initiatives for cell research
  •   Key Market Drivers

  • Increasing expenditure on cell level research by the corporate sector
  • rising occurrence of cell-specific diseases


  • Speak to Analyst Ask for Customization

    Frequently Asked Questions (FAQ) :

    Need for anticancer treatment, increased expenditure on cell research, and rising incidence of chronic diseases are major drivers of the global cell cycle analysis market.

    The Americas have registered the largest share in the global cell cycle analysis market due to presence of research and development facilities.

    Europe is the second largest in the global cell cycle analysis market due to establishment of research institutes and life science companies.

    Miltenyi Biotech, Promega Corporation, Danaher Corporation, Nexcelom Bioscience LLC., Becton, Dickinson and Company, Agilent Technologies, Inc., GE Healthcare, Olympus Corporation, Merck & Co., Inc., PerkinElmer, Inc., Bio-Rad Laboratories, Inc., and Thermo Fisher Scientific, Inc. are major players of the global cell cycle analysis market.

    Acquisitions are the major strategy being incorporated by players in the global cell cycle analysis market.